Methylphenidate in the treatment of children with attention-deficit hyperactivity disorder
about
Packages of care for attention-deficit hyperactivity disorder in low- and middle-income countriesBupropion, methylphenidate, and 3,4-methylenedioxypyrovalerone antagonize methamphetamine-induced efflux of dopamine according to their potencies as dopamine uptake inhibitors: implications for the treatment of methamphetamine dependence.Effectiveness and safety of a long-acting, once-daily, two-phase release formulation of methylphenidate (Ritalin ® LA) in school children under daily practice conditions.The clinical impact of switching attention deficit hyperactivity disorder patients from OROS(®)-MPH to Novo-MPH ER-C(®): A paediatric practice review.
P2860
Methylphenidate in the treatment of children with attention-deficit hyperactivity disorder
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Methylphenidate in the treatme ...... deficit hyperactivity disorder
@ast
Methylphenidate in the treatme ...... deficit hyperactivity disorder
@en
Methylphenidate in the treatme ...... deficit hyperactivity disorder
@nl
type
label
Methylphenidate in the treatme ...... deficit hyperactivity disorder
@ast
Methylphenidate in the treatme ...... deficit hyperactivity disorder
@en
Methylphenidate in the treatme ...... deficit hyperactivity disorder
@nl
prefLabel
Methylphenidate in the treatme ...... deficit hyperactivity disorder
@ast
Methylphenidate in the treatme ...... deficit hyperactivity disorder
@en
Methylphenidate in the treatme ...... deficit hyperactivity disorder
@nl
P2860
P1476
Methylphenidate in the treatme ...... deficit hyperactivity disorder
@en
P2093
B Vitiello
P2860
P304
P407
P577
2001-11-27T00:00:00Z